Article info

Download PDFPDF

Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials
Free
  1. Correspondence to:
    Dr R Rau, Rheumaklinik, Evangelisches Fachkrankenhaus, Rosenstr 2 D-40882 Ratingen, Germany;
    rrau{at}uni-duesseldorf.de
View Full Text

Citation

Rau R
Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

Publication history

  • First published November 1, 2002.
Online issue publication 
November 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.